<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 8.8: Modern Diagnostic Frameworks: DSM-5-TR and ICD-11</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/PURPLE theme for Diagnostic Frameworks */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #334155;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Lists */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .content-list {
            font-size: 17px;
            margin: 20px 0;
            padding-left: 24px;
        }

        .content-list li {
            margin-bottom: 14px;
            line-height: 1.7;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0e7ff 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #1e3a8a;
        }

        .stat-highlight {
            font-weight: 700;
            color: #1e40af;
            background: #f1f5f9;
            padding: 2px 6px;
            border-radius: 4px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e2e8f0;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e2e8f0;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            text-align: left;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fffcf0;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 24px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
            font-size: 15px;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f8fafc;
            padding: 30px;
            margin: 40px 0;
            border-radius: 14px;
            border-left: 6px solid #1e3a8a;
        }

        .references-box {
            background: #ffffff;
            padding: 30px;
            margin-top: 40px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            color: #888;
            font-size: 13px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 8: Clinical Assessment & Diagnostic Evolution</p>
            <h1 class="lesson-title">Lesson 8.8: Modern Diagnostic Frameworks: DSM-5-TR and ICD-11</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üìö Lesson 8 of 12</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#dsm5tr"><span class="section-num">1</span>The DSM-5-TR Evolution</a></li>
                <li><a href="#icd11"><span class="section-num">2</span>ICD-11: A Global Perspective</a></li>
                <li><a href="#framework-comparison"><span class="section-num">3</span>Framework Comparison</a></li>
                <li><a href="#neurodiversity"><span class="section-num">4</span>The Neurodiversity Paradigm</a></li>
                <li><a href="#bias-gender"><span class="section-num">5</span>Cultural Bias & The Gender Gap</a></li>
                <li><a href="#future-biomarkers"><span class="section-num">6</span>The Future of Objective Diagnosis</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the critical updates in the <span class="highlight">DSM-5-TR</span>, specifically regarding adult symptom thresholds and age of onset.</li>
                <li>Evaluate the <span class="highlight">ICD-11</span> criteria and its descriptive approach to lifespan ADHD.</li>
                <li>Synthesize the shift from a "medical deficit" model to a <span class="highlight">neurodiversity-affirming</span> diagnostic approach.</li>
                <li>Identify and mitigate systemic cultural and gender biases in the diagnostic process.</li>
                <li>Explore the emerging role of biomarkers and digital phenotyping in future diagnostic standards.</li>
            </ul>
        </div>

        <h2 id="dsm5tr">1. The DSM-5-TR Evolution: Refining the ADHD Construct</h2>
        <p>In March 2022, the American Psychiatric Association released the <span class="highlight">DSM-5-TR (Text Revision)</span>. While not a full overhaul like the shift from DSM-IV to DSM-5, the TR provided essential clarifications that reflect our deepening understanding of ADHD as a lifelong neurodevelopmental condition. One of the most significant shifts was the formalization of the <span class="stat-highlight">age of onset</span> and the adjustment of symptom counts for adults.</p>
        
        <p>Historically, the DSM-IV required symptoms to be present before age 7. The DSM-5 increased this to age 12, recognizing that executive function demands often do not exceed a child's capacity until middle school. The TR maintains this but emphasizes that while symptoms must be present by 12, they may not be <em>recognized</em> until much later in life‚Äîa crucial distinction for adult diagnosis.</p>

        <h3 id="adult-thresholds">The "Adult" Threshold</h3>
        <p>A landmark change in the current DSM framework is the reduction of the symptom threshold for individuals aged 17 and older. While children require 6 out of 9 symptoms in either the Inattentive or Hyperactive-Impulsive domains, adults only require <span class="stat-highlight">5 symptoms</span>. This change was supported by a 2021 meta-analysis showing that the 5-symptom threshold for adults yields the highest diagnostic stability and clinical utility (Faraone et al., 2021).</p>

        <h2 id="icd11">2. ICD-11: The Global Standard for ADHD</h2>
        <p>The World Health Organization‚Äôs <span class="highlight">ICD-11</span> (International Classification of Diseases, 11th Revision) represents a significant departure from its predecessor, ICD-10. Where ICD-10 used the narrow term "Hyperkinetic Disorder," ICD-11 has adopted "Attention Deficit Hyperactivity Disorder," aligning more closely with global research and the DSM.</p>

        <p>The ICD-11 is notably more "descriptive" than "prescriptive." Instead of a rigid list of 18 symptoms, it provides detailed descriptions of how ADHD manifests across the lifespan. For example, it explicitly mentions that in adolescents and adults, <span class="highlight">overt motor hyperactivity</span> may be replaced by "internalized restlessness" or an inability to remain sedentary for long periods.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: The "Late" Discovery</p>
                    <p style="color:white; font-size:12px; margin:0;">Adult Diagnosis & DSM-5-TR Criteria</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-info">
                        <h4>Elena, 34</h4>
                        <p>Graphic Designer | Presenting with Burnout and Chronic Disorganization</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Elena sought help for "treatment-resistant depression." She reported a lifetime of feeling "behind," struggling with deadlines, and an inability to keep her home organized. She did not consider herself hyperactive as a child.</p>
                <p><strong>Diagnostic Shift:</strong> Under DSM-IV (pre-2013), Elena would have failed the age-7 onset rule. Under DSM-5-TR, the practitioner explored her middle-school years (ages 11-12), uncovering significant "daydreaming" and "careless mistakes" that were dismissed because she was a high-achiever. By applying the <span class="stat-highlight">5-symptom adult threshold</span>, she met criteria for ADHD, Predominantly Inattentive Presentation.</p>
                <p><strong>Outcome:</strong> Transitioning from depression treatment to ADHD-specific support (EF coaching and stimulant medication) resulted in a 65% reduction in perceived stress within 3 months.</p>
            </div>
        </div>

        <h2 id="framework-comparison">3. Framework Comparison: DSM-5-TR vs. ICD-11</h2>
        <p>As a Support Specialist, understanding the subtle differences between these two "bibles" of psychiatry is vital for interpreting clinical reports from international clients or diverse medical teams.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>DSM-5-TR (APA)</th>
                        <th>ICD-11 (WHO)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Terminology</strong></td>
                        <td>ADHD (Presentations)</td>
                        <td>ADHD (Patterns)</td>
                    </tr>
                    <tr>
                        <td><strong>Symptom Count</strong></td>
                        <td>Strict: 6/9 (Kids), 5/9 (Adults)</td>
                        <td>Descriptive: Focus on functional impact</td>
                    </tr>
                    <tr>
                        <td><strong>Age of Onset</strong></td>
                        <td>Symptoms present before age 12</td>
                        <td>Symptoms present during developmental period</td>
                    </tr>
                    <tr>
                        <td><strong>Autism Co-occurrence</strong></td>
                        <td>Allowed (since 2013)</td>
                        <td>Allowed</td>
                    </tr>
                    <tr>
                        <td><strong>Global Use</strong></td>
                        <td>Primary in North America</td>
                        <td>Primary in Europe/Global health reporting</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="neurodiversity">4. The Neurodiversity Paradigm: From Deficit to Difference</h2>
        <p>While the DSM and ICD are essential for insurance and medical intervention, the <span class="highlight">Neurodiversity Paradigm</span> offers a parallel framework for support. This model views ADHD not as a "broken brain," but as a naturally occurring variation in the human genome.</p>

        <p>A 2023 study published in <em>The Lancet</em> suggested that the medical model's focus on "impairment" often misses the <span class="highlight">situational nature</span> of ADHD. For example, an individual may be highly impaired in a traditional corporate office but thrive in a high-stimulation, creative, or crisis-driven environment. This aligns with the "Evolutionary Mismatch Theory" discussed in Module 1.</p>

        <div class="alert-box info">
            <p class="alert-label">Practitioner Insight</p>
            <p>The modern practitioner uses the DSM/ICD for <strong>validation and access</strong>, but uses the Neurodiversity Paradigm for <strong>empowerment and strategy</strong>. We don't "fix" the ADHD; we optimize the environment to fit the neurotype.</p>
        </div>

        <h2 id="bias-gender">5. Cultural Bias & The Gender Gap in Identification</h2>
        <p>Diagnostic tools are only as good as the data they were built on. Historically, ADHD research was conducted primarily on young, white males. This has led to a massive <span class="highlight">Gender Gap</span> and <span class="highlight">Cultural Bias</span> in diagnosis.</p>

        <h3 id="masking">The Female Phenotype & Masking</h3>
        <p>Research indicates that girls are diagnosed with ADHD at a rate of roughly 1:3 compared to boys, yet in adulthood, the ratio approaches 1:1. This suggests that millions of girls are "missed" due to <span class="highlight">masking</span>‚Äîthe conscious or unconscious suppression of ADHD traits to meet social expectations. Girls often present with internal restlessness rather than external disruption, leading to misdiagnoses of Anxiety or Borderline Personality Disorder.</p>

        <h3 id="cultural-bias">Socioeconomic and Cultural Factors</h3>
        <p>A 2022 meta-analysis found that children from minority backgrounds in the US are <span class="stat-highlight">24% less likely</span> to receive an ADHD diagnosis than white children with similar symptom profiles, often because their behaviors are misinterpreted through a lens of "conduct issues" rather than neurodevelopmental needs.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üåç</div>
                <div>
                    <p class="box-label">Case Study: Cultural Misinterpretation</p>
                    <p style="color:white; font-size:12px; margin:0;">Implicit Bias in School Settings</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-info">
                        <h4>Marcus, 9</h4>
                        <p>African American Male | Referred for "Defiance" and "Aggression"</p>
                    </div>
                </div>
                <p><strong>Initial Assessment:</strong> School reports focused on Marcus's "refusal to follow directions" and "loud outbursts." He was at risk for suspension.</p>
                <p><strong>The "Method" Intervention:</strong> A specialist used a neuro-affirming lens to observe Marcus. They found his "defiance" was actually <span class="highlight">auditory processing delay</span> (common in ADHD), and his "aggression" was a sensory-seeking response to a crowded, noisy classroom.</p>
                <p><strong>Outcome:</strong> Once Marcus was diagnosed with ADHD (Hyperactive-Impulsive type) and provided with noise-canceling headphones and a "movement break" protocol, his "conduct issues" vanished. His grades improved by two letter levels in one semester.</p>
            </div>
        </div>

        <h2 id="future-biomarkers">6. Future Directions: The Quest for Objective Criteria</h2>
        <p>The "Holy Grail" of ADHD research is the move from subjective checklists to objective <span class="highlight">biomarkers</span>. While we are not there yet, several technologies are showing promise in clinical trials:</p>
        
        <ul class="content-list">
            <li><strong>Quantitative EEG (qEEG):</strong> Measuring "Theta/Beta Ratios." A high ratio often correlates with ADHD, though it is not yet definitive for diagnosis.</li>
            <li><strong>Eye-Tracking Technology:</strong> A 2023 study (n=450) showed that individuals with ADHD have distinct microsaccade (tiny eye movement) patterns when attempting to focus.</li>
            <li><strong>Genetic Risk Scores (PRS):</strong> Using polygenic risk scores to identify infants at high risk for ADHD, allowing for early environmental interventions before symptoms become impairing.</li>
            <li><strong>Digital Phenotyping:</strong> Using smartphone usage patterns (typing speed, app switching, sleep cycles) to track symptom fluctuations in real-time.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. What is the minimum number of symptoms required for an ADHD diagnosis in a 25-year-old adult according to the DSM-5-TR?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">According to the DSM-5-TR, individuals aged 17 and older require only <strong>5 symptoms</strong> (compared to 6 for children) in either the inattentive or hyperactive-impulsive domains.</div>
            </div>
            <div class="question-item">
                <p class="question-text">2. How does the ICD-11 approach to hyperactivity differ from earlier versions for adult patients?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The ICD-11 recognizes that overt motor hyperactivity (running/climbing) often transitions into <strong>internalized restlessness</strong> or an inability to engage in quiet/sedentary activities in adults.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The <span class="highlight">DSM-5-TR</span> maintains the age 12 onset but allows for retrospective diagnosis in adults with a lower 5-symptom threshold.</li>
                <li>The <span class="highlight">ICD-11</span> provides a more descriptive, lifespan-oriented framework that is becoming the global standard.</li>
                <li>Diagnosis is often delayed or missed in females and minority populations due to <span class="highlight">masking</span> and <span class="highlight">implicit bias</span>.</li>
                <li>The <span class="highlight">Neurodiversity Paradigm</span> shifts the focus from "impairment" to "environmental fit," viewing ADHD as a different neurotype.</li>
                <li>The future of diagnosis lies in combining clinical observation with <span class="highlight">objective biomarkers</span> like eye-tracking and qEEG.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <p>American Psychiatric Association. (2022). "Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR)." <em>APA Publishing.</em></p>
            <p>Faraone, S. V., et al. (2021). "The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder." <em>Neuroscience & Biobehavioral Reviews.</em></p>
            <p>World Health Organization. (2019/2022). "International Classification of Diseases for Mortality and Morbidity Statistics (11th Revision)." <em>WHO Press.</em></p>
            <p>Hinshaw, S. P., et al. (2022). "Annual Research Review: Attention-deficit/hyperactivity disorder in girls and women: underdiagnosis, dysfunction, and transformation." <em>Journal of Child Psychology and Psychiatry.</em></p>
            <p>Barkley, R. A. (2020). "ADHD as a Disorder of Self-Regulation and Executive Function: Implications for Diagnosis." <em>Clinical Child and Family Psychology Review.</em></p>
            <p>Chung, W., et al. (2023). "Objective diagnosis of ADHD using eye-tracking and machine learning: A large-scale validation study." <em>The Lancet Digital Health.</em></p>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Certified ADHD Support Specialist (CASS)</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Proprietary Certification Content.</p>
        </footer>
    </div>
</body>

</html>